knowledge -WSS

knowledge

author：leisure time 2025-09-28 18:31:01 - browse：85

Bristol Myers Squibb sign — Courtesy Bristol Myers Squibb

Bristol Myers Squibb said that it would purchase Mirati Therapeutics, maker of the cancer drug Krazati, for $4.8 billion in cash in a deal that shows the continued interest of large pharmaceutical firms in relatively small “bolt-on” acquisitions.

Bristol said that it would pay $58.00 per share for Mirati, and would hold another $12.00 per share, or a total of $1 billion, to be paid if one of two different applications for an additional use for Krazati is approved within seven years after the merger closes.

Chris Boerner, Bristol’s chief operating officer and CEO-elect, said in a statement that Mirati had several cancer drugs in development that could deliver sales in the latter half of the decade and beyond, when investors worry that Bristol will need new products to sustain its growth.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Biotech lab space demand falls sharply

WSS

Readout LOUD podcast: possible new ALS drug, artificial wombs

More regulation could be coming for drug ads

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Judge rejects Trump's counterclaim against E. Jean Carroll

Former Georgia lieutenant governor says he received grand jury subpoena

CDC's new outbreak response network to include Northeastern

focus

knowledge

focus

Apple is now the first public company to be valued at $3 trillion

NYC struggling to keep up with demand of supporting asylum seekers, Mayor Adams says

Trump demands the U.S. pay no more for drugs than other countries … again

Choosing scientific sides in the fight against Alzheimer's

Drug repurposing or repositioning? The language matters

Travel bans should be based on evidence, not politics or fear

Malaria cases in Florida and Texas: Here’s what you need to know

How AI helped researchers track recovery from depression

Malaria cases in Florida and Texas: Here’s what you need to know

How Vertex's cystic fibrosis drug is changing patients' lives

hotspot

CDC launches VaccineFinder tool to locate Covid

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

Lasker Awards 2023: Winners in biomedical research

Choosing scientific sides in the fight against Alzheimer's

Germany receives 178 compensation applications from gay servicepeople over discrimination

Discs beat pads, tampons for heavy menstrual flow, new study shows

hotspot

entertainment

focus

entertainment